GMP IPO
📋 Filings Intelligence
About Contact
LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

-
Filed today
-
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Aspira Pathlab & Diagnostics Ltd

Aspira Pathlab Q2 FY27 Board Approves Un-audited Financial Results

FUNDRAISE ● No Immediate Change LOW RISK
📅 Filed on BSE: 06 Nov 2026, 04:22 PM IST  ·  BSE ID: fdbfc0eb-355e-43f8-bb44-99b7688b0914
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's board met to approve its latest financial performance report for the July-September 2026 quarter.
🤖 AI Summary
  • Aspira Pathlab & Diagnostics Ltd's Board approved Q2 FY27 unaudited standalone financial results on November 6, 2026.
  • The results cover the second quarter and the half-yearly period ending September 30, 2026.
  • Auditor's limited review report on the financial results was also considered and taken on record.
  • The meeting was held in Mumbai and concluded within a 2.5-hour timeframe.
🏢 How This Affects the Company
💰
Financial Impact
The approval of financial results marks a standard reporting event for the company, providing investors with its latest financial performance metrics.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders regarding this announcement.
👤
Who Is Affected
All shareholders of Aspira Pathlab & Diagnostics Ltd are informed of the company's financial reporting status as of Q2 FY27.
🔍
Management Signal
Management is adhering to regulatory requirements for timely disclosure of financial performance.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events
Q3 FY27 financial results release
Announcement of any new diagnostic center openings
Updates on revenue and profit growth trends
LOW RISK Routine financial results disclosure with no material new information disclosed.
💡 Investor Takeaway
Aspira Pathlab & Diagnostics Ltd's Board has approved the unaudited standalone financial results for Q2 FY27 and the half-year ended September 30, 2026, along with the auditor's limited review report.
⚖️ Strengths & Concerns

✅ Positives

  • Board approval of financial results and auditor's limited review report completed on schedule.
  • Disclosure adheres to SEBI (LODR) Regulations, 2015, ensuring regulatory compliance.
❓ Frequently Asked Questions
What did the Aspira Pathlab & Diagnostics Ltd Board approve on November 6, 2026?
The Board approved the unaudited standalone financial results for the second quarter and half-yearly period ended September 30, 2026, along with the auditor's limited review report.
Which period do the approved financial results for Aspira Pathlab & Diagnostics Ltd cover?
The results cover the second quarter and the half-yearly period ended September 30, 2026.
Was there a limited review by auditors on Aspira Pathlab's financial results?
Yes, the Board of Directors took on record the auditor's limited review report on the unaudited standalone financial results for the second quarter and half-yearly period ended September 30, 2026.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.